Trial Profile
Efficacy of epinastine hydrochloride ophthalmic solution in the patients with perennial allergic conjunctivitis after treating with olopatadine hydrochloride ophthalmic solution.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Allergic conjunctivitis; Pruritus
- Focus Therapeutic Use
- 30 Dec 2014 New trial record